Synopsis
0
EU WC
0
KDMF
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
63
PharmaCompass offers a list of Streptomycin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Streptomycin manufacturer or Streptomycin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Streptomycin manufacturer or Streptomycin supplier.
PharmaCompass also assists you with knowing the Streptomycin API Price utilized in the formulation of products. Streptomycin API Price is not always fixed or binding as the Streptomycin Price is obtained through a variety of data sources. The Streptomycin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Strepto Fatol manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Strepto Fatol, including repackagers and relabelers. The FDA regulates Strepto Fatol manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Strepto Fatol API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Strepto Fatol manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Strepto Fatol supplier is an individual or a company that provides Strepto Fatol active pharmaceutical ingredient (API) or Strepto Fatol finished formulations upon request. The Strepto Fatol suppliers may include Strepto Fatol API manufacturers, exporters, distributors and traders.
click here to find a list of Strepto Fatol suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Strepto Fatol DMF (Drug Master File) is a document detailing the whole manufacturing process of Strepto Fatol active pharmaceutical ingredient (API) in detail. Different forms of Strepto Fatol DMFs exist exist since differing nations have different regulations, such as Strepto Fatol USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Strepto Fatol DMF submitted to regulatory agencies in the US is known as a USDMF. Strepto Fatol USDMF includes data on Strepto Fatol's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Strepto Fatol USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Strepto Fatol suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Strepto Fatol Drug Master File in Japan (Strepto Fatol JDMF) empowers Strepto Fatol API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Strepto Fatol JDMF during the approval evaluation for pharmaceutical products. At the time of Strepto Fatol JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Strepto Fatol suppliers with JDMF on PharmaCompass.
A Strepto Fatol CEP of the European Pharmacopoeia monograph is often referred to as a Strepto Fatol Certificate of Suitability (COS). The purpose of a Strepto Fatol CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Strepto Fatol EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Strepto Fatol to their clients by showing that a Strepto Fatol CEP has been issued for it. The manufacturer submits a Strepto Fatol CEP (COS) as part of the market authorization procedure, and it takes on the role of a Strepto Fatol CEP holder for the record. Additionally, the data presented in the Strepto Fatol CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Strepto Fatol DMF.
A Strepto Fatol CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Strepto Fatol CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Strepto Fatol suppliers with CEP (COS) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Strepto Fatol as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Strepto Fatol API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Strepto Fatol as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Strepto Fatol and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Strepto Fatol NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Strepto Fatol suppliers with NDC on PharmaCompass.
Strepto Fatol Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Strepto Fatol GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Strepto Fatol GMP manufacturer or Strepto Fatol GMP API supplier for your needs.
A Strepto Fatol CoA (Certificate of Analysis) is a formal document that attests to Strepto Fatol's compliance with Strepto Fatol specifications and serves as a tool for batch-level quality control.
Strepto Fatol CoA mostly includes findings from lab analyses of a specific batch. For each Strepto Fatol CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Strepto Fatol may be tested according to a variety of international standards, such as European Pharmacopoeia (Strepto Fatol EP), Strepto Fatol JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Strepto Fatol USP).
